strain brands

NDV STRAIN “LASOTA” 105,5 EID50 AND IBV STRAIN “B/48” 102.6 EID50

AT LEAST 102.7 TCID50 OF LIVE FOWLPOX VIRUS, STRAIN HP-2.

3.7LOG10 EID50

1.26 X 7LOG10 CCU

NEWCASTLE DISEASE VIRUS B1 TYPE, B1 STRAIN 6.4LOG10 EID50 + INFECTIOUS BRONCHITIS VIRUS MASSACHUSETTS TYPE, M-48 STRAIN 3.7LOG10 EID50

2-8 X 105 CFU

>10 EID 50(NDV) AND >106.5 EID IV VIRUS

EACH DOSE (0.5 ML) OF VACCINE CONTAINSINACTIVATED NEWCASTLE DISEASE VIRUS, STRAIN NDV-SZ LASOTA INDUCING MIN. 6 LOG2 HI TITRE WITH 1 DOSE OR INDUCING MIN. 4 LOG2 HI TITRE WITH 1/50 DOSE OR MIN. 50 PD50 INACTIVATED AVIAN INFECTIOUS BRONCHITIS VIRUS,STRAI

MIN. 2.8 LOG10 EID50 PER DOSE

MAREK’S DISEASE, HVT STRAIN…………AT LEAST 2164 PFU PER DOSE THROUGH EXPIRATION. MAREK’S DISEASE, RISPENS CVI988 STRAIN……….. AT LEAST 1322 PFU PER DOSE THROUGH EXPIRATION. WITH CRYOPROTECTANTS: CRYOPROTECTANT NO. 1 + HVT AND RISPENS CVI988 STRAINS..…….50-90%

INACTIVATED NEWCASTLE DISEASE VIRUS STRAIN NDV-SZ LASOTA …….. INDUCING MIN. 4 LOG2 HI OR MIN. 50 PD50

NEWCASTLE DISEASE VIRUS STRAIN LASOTA MIN 5.5 LOG10 EID50/DOSE

LIVE ATTENUATED AVIAN INFECTIOUS BURSAL DISEASE VIRUS, STRAIN WINTERFIELD 2512, G-61 MIN 0.1CID50 PER DOSE

NEWCASTLE DISEASE VIRUS STRAIN PHY.LMV.42 AT LEAST 5.5 LOG10 EID50 AVIAN INFECTIOUS BRONCHITIS VIRUS STRAIN H120 AT LEAST 3.3 LOG10 EID50

INACTIVATED NEWCASTLE DISEASE VIRUS STRAIN NDV-SZ LASOTA ………………… INDUCING MIN. 5 LOG2 HI TITER OR MIN. 50 PD50 IN CHALLENGE

ACCEPTANCE RANGE FOR ANTIGEN CONTENT: 3.9-10.4U/DOSE (TARGET ANTIGEN CONTENT: 6.5U/DOSE)

>10 6 PFU

1 ML/DOG

1 DOSE/BIRD

1 DOSE/BIRD

1 DOSE/BIRD

1 DOSE/BIRD

1 DOSE PER BIRD

ONE DOSE (0.5 ML) CONTAINS: POLIOVIRUS# TYPE 1 MAHONEY STRAIN (INACTIVATED) ............................ 40 DU* POLIOVIRUS# TYPE 2 MEF-1 STRAIN (INACTIVATED) ................................ 8 DU* POLIOVIRUS# TYPE 3 SAUKETT STRAIN (INACTIVATED

0.5ML

EID 50 > 10 POWER 6/DOSES PER 0.3ML

A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180) - (15 ?G HAEMAGGLUTININ/DOSE) A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B) - (15 ?G HAEMAGGLUTININ/DOSE) B/BRISBANE/60/2008-LIKE STRAIN (B/BR

NDV STRAIN “LASOTA” MIN. 50 PD 50 AND EDS STRAIN “B8/78” INDUCED MIN. 7 LOG HI AND IBV STRAIN “M/41” INDUCED MIN. 6 LOG2 HI

103.0 TCID50 OF LIVE AVIAN INFECTIOUS BURSAL DISEASE VIRUS STRAIN D78.

106.0 EID50 OF LIVE NEWCASTLE DISEASE VIRUS STRAIN LA SOTA

0.15MG OF MYCOPLASMA CAPRICOLUM PER ML, STRAIN F38 BIOTYPE

10POWER 2.5(TCID50) PER DOSE

EACH 0.1 CONTAINS: WATER PHASE CONTAINING INACTIVATED NDV, V.H STRAIN. AT LEAST 10 POWER 8.1EID 50

EID 50 > 10 POWER 6/DOSES PER 0.3ML

EACH DOSE CONTAINS ATLEAST 10^2.5EID50 AVIAN ENCEPHALOMYELITIS VIRUS STRAIN CALNEK 1143 AND 102.58EID50 FOWL POX VIRUS.

EACH DOSE CONTAINS ATLEAST 4.0 LOG10TCID50 OF INFECTIOUS BURSA DISEASE(GUMBORO) VIRUS STRAIN D78.

EACH DOSE CONTAINS ATLEAST 10^3EID50 INFECTIOUS BRONCHITIS VIRUS STRAIN MA5 AND 106EID50 OF THE NEWCASTLE DISEASE STRAIN CLONE 30.

EACH VIAL CONTAINS ATLEAST 6.0 LOG10 EID50 OF LIVE NEWCASTLE DISEASE VIRUS STRAIN LASOTA

ND CLONE 3050 PD50

INACTIVATED INFECTIOUS BRONCHITIS VIRUS MASSACHUSETTS SEROTYPE STRAIN 41 NEWCASTLE DISEASE VIRUS COLNE 30 GUMBORO VIRUS STRAIN D78AND REO VIRUS STRAIN 1733 AND 2408.

MAREK DISEASE SEROTYPE1 STRAIN CVI - 988

EACH 0.1-ML DOSE (2 DROPS) CONTAINS:POLIOMYELITIS VIRUS TYPE 1, LS C2AB STRAIN, (LIVE, ATTENUATED) AT LEAST 6.0 LOG CCID50 ,POLIOMYELITIS VIRUS TYPE 3, LEON 12A1B STRAIN, (LIVE, ATTENUATED) AT LEAST 5.8 LOG CCID50

75/1 10 POWER 2.5 (TCID 50) PER DOSE

VIRUS POLIO TYPE 1, STRAIN LSC, 2AB >10^6.0CCID^50; VIRUS POLIO TYPE 3, STRAIN LEON 12A >10^5.8CCID^50

EACH DOSE OF 2 DROPS (0.1ML) CONTAINS POLIO VIRUS (SABIN) OPV SABIN BIVALENT STRAIN TYPE I AND III VIRUSES: NOT LESS THAN 6.21 LGCCID50/DOSE OPV SABIN STRAIN TYPE I VIRUSES: NOT LESS THAN 6.0 LGCCID50/DOSE OPV SABIN STRAIN TYPE III VIRUSES: NOT LESS THAN

EACH DOSE CONTAINS, AT LEAST, 102.0 EID50 OF LIVE (V877) STRAIN OF INFECTIOUS BURSAL DISEASE (GUMBORO) VIRUS

LIVE ATTENUATED NEWCASTLE DISEASE VIRUS, STRAIN ULSTER 2C: 105.7-106.6 EID50 PER DOSE

VARIOUS

VCC 1.0 X 1010 CFU/ML FOR EACH TYPE

INACTIVATED AND CONCENTRATED NEWCASTLE DISEASE VIRUS, B1 TYPE MIN 108.8 EID50 INACTIVATED AND CONCENTRATED INFECTIOUS BRONCHITIS VIRUS MASSACHUSETTS TYPE, STRAIN M-41 MIN 106.1 EID50 INACTIVATED AND CONCENTRATED INFECTIOUS BRONCHITIS VIRUS MASSACHUSETTS T